News

Longeveron Inc. Plans Exciting Third Quarter Financial Update

Longeveron Inc. Plans Exciting Third Quarter Financial Update

Longeveron Inc.'s Upcoming Financial Disclosure

In an exciting announcement, Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company at the forefront of advancing cellular therapies for severe, rare pediatric conditions and chronic aging-related issues, is gearing up to share its financial results for the third quarter of 2025. This much-anticipated event will take place after the closure of the U.S. financial markets on November 4, 2025. Alongside the financial results, Longeveron will provide a comprehensive business update during a conference call scheduled for 4:30 p.m. ET on the same day.

Details on the Conference Call

The conference call will offer stakeholders an opportunity to gain insights into Longeveron’s developments and strategic direction. Participants can join the conversation via the following:

Conference Call Number: 1.877.407.0789

Conference ID: 13755997

Attendees can also access a live webcast of the conference call, which will be available through Longeveron's official channels. This ensures that all interested parties can engage with the critical information regarding the company's ongoing endeavors.

Access to Archived Content

For those unable to participate in real time, Longeveron will provide a replay of the webcast in the 'Events & Presentations' section of its website. This feature is especially beneficial for investors and analysts keen on reviewing the insights shared during the call and ensuring they stay informed about the latest developments within the company.

About Longeveron Inc.

Longeveron Inc. stands out in the biotechnology space, focusing on developing regenerative medicines aimed at addressing substantial medical needs. The company’s lead investigational product, laromestrocel (Lomecel-B™), is an allogeneic mesenchymal stem cell therapy. Derived from the bone marrow of healthy young adult donors, laromestrocel operates through diverse mechanisms that facilitate vascular growth, promote regeneration, and reduce inflammation.

Field-Driven Pipeline Focus

The therapeutic potential of laromestrocel spans numerous disease areas. Longeveron is actively pursuing multiple critical indications, including hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, pediatric dilated cardiomyopathy (DCM), and aging-related frailty. The rigorous development of laromestrocel has been acknowledged by the FDA, granting it several important designations: Orphan Drug, Fast Track, and Rare Pediatric Disease designations for HLHS, alongside Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations for Alzheimer’s.

Investor and Community Engagement

Longeveron embraces transparency and actively engages with its investor community and the public. As the company moves forward, it encourages individuals to learn more about its mission and innovative products through its official website. The company maintains an active presence on various social media platforms where they share updates and insights regularly.

Stay Connected:

Contact Information:
Derek Cole
Investor Relations Advisory Solutions
derek.cole@iradvisory.com

Frequently Asked Questions

What will Longeveron report on November 4, 2025?

Longeveron will announce its third quarter 2025 financial results and provide an important business update.

How can I access the conference call?

You can join the conference call by calling 1.877.407.0789 and entering Conference ID 13755997.

Will there be a replay available after the call?

Yes, an archived replay of the webcast will be accessible on the events section of Longeveron’s website.

What is laromestrocel?

Laromestrocel (Lomecel-B™) is a mesenchymal stem cell therapy that aims to address various medical conditions through several regenerative processes.

What designations has Longeveron received for its therapies?

Longeveron has received critical FDA designations such as Orphan Drug, Fast Track, and RMAT designations for its various therapeutic programs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 162

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 29

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 213

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 90

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 132

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 101

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 138

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 66

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 208

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading

Top 5 Most Recently Viewed Articles

Alliance Entertainment Expands Leadership with Robert Oram

Updated Category News Views 137

Alliance Entertainment Welcomes Robert Oram as EVP Alliance Entertainment Holding Corporation (NASDAQ: AENT) has made a significant addition to its leadership team with the appointment of Robert Oram as the Executive Vice President. This strategic move, announced recently, aims to bolster the company's efforts in expanding its home entertainment division. Oram, a veteran...

Continue Reading
Teradyne Inc: Navigating AI Growth in Semiconductor Testing

Updated Category News Views 155

Teradyne Inc (NASDAQ: TER) was one of those stocks that had traders buzzing back in 2023 when it saw gains up to 50% early in the year. That kind of momentum, especially outpacing the Philadelphia Semiconductor Index, had folks dreaming big. But reality hit later on as the market pulled back, reminding everyone that nothing lasts forever in this volatile game. Market...

Continue Reading
Transforming Landscapers' Cash Flow with Duranta's Payments

Updated Category News Views 163

Duranta Unveils a Game-Changer for Landscapers' Payments Duranta, the AI-driven platform for landscaping professionals, is set to reshape how landscaping businesses handle payments. Recently, they introduced an innovative feature that embeds secure payment links directly into customer invoices. This new function streamlines transaction methods for landscapers, making it...

Continue Reading
Analyzing Market Trends: The Case of WR Berkley Stock

Updated Category News Views 146

Understanding WR Berkley and Its Market Position WR Berkley Corporation (NYSE: WRB) has been making headlines recently due to its fluctuating short interest levels. The company, known for its diverse insurance offerings, recorded a significant rise in its short percent of float, now standing at 22.48%. This figure comes from its recent announcement that approximately 7.96...

Continue Reading
Timbercreek Financial to Host Q4 Results Call - Key Details Inside

Updated Category News Views 153

Timbercreek Financial's Upcoming Conference Call Timbercreek Financial (TSX: TF) is gearing up for an important conference call to discuss its financial results for the last quarter. This call is set for 1:00 p.m. (ET) on a Wednesday. The insights into the company’s performance will be revealed shortly after the markets close. Stakeholders and interested parties are...

Continue Reading